CDC advisory panel to consider third COVID-19 shot for immunocompromised

The Centers for Disease Control and Prevention’s (CDC) vaccine advisory panel will consider a third COVID-19 shot for immunocompromised individuals.

The panel will meet on July 22 to discuss “clinical considerations for additional doses in immunocompromised individuals,” the meeting’s agenda states. 

Heavy debate around a third COVID-19 shot sparked last week after Pfizer said it would seek authorization from the Food and Drug Administration (FDA) for a third dose of its vaccine. ...

Israel has begun administering a third dose of Pfizer’s COVID-19 vaccine to people with weak immune systems. This includes people with cancer, people who have undergone liver transplants and others who have weak protection from the vaccine.

However, the Israeli government indicated that it was unsure about administering a third dose to the general population.